Patent · US Expired

Heliothis expression systems

US5041379A · kind A · utility

13Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 1988
Grant dateAug 20, 1991
Priority date
Expiry dateMar 14, 2008

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to recombinant vector/host systems which can direct the expression of foreign genes under the control of the Heliothis polyhedrin promoter. Using the systems of the present invention, a heterologous gene of interest can be expressed as an unfused peptide or protein, a fusion protein, or as a recombinant occlusion body which comprises crystallized polyhedrin fusion proteins bearing the heterologous gene product on the surface of or within the occlusion body. The recombinant proteins or occlusion bodies of the present invention have uses in vaccine formulations and immunoassays, as biological insecticides, and as expression systems for the production of foreign peptides or proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.